SCHEMBL7051445

SCHEMBL7051445

O=C(NCC(C(=O)NCCCCc1ccccc1)c1ccc(O)cc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.56
RAB9A P51151 3/20 0.56
KDM4A O75164 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.53
HSP90AA1 P07900 1/20 0.52
TRPV1 Q8NER1 1/20 0.51
MLYCD O95822 1/20 0.49
CNR1 P21554 1/20 0.49
ESRRG P62508 1/20 0.47
POLB P06746 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
HDAC1 Q13547 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7047062 0.82 NPC1 (0.46) NPC1RAB9AKDM4ASMN1; SMN2HSP90AA1
SCHEMBL7052528 0.82 PKM (0.52) NPC1RAB9AKDM4ASMN1; SMN2HSP90AA1
SCHEMBL27658471 0.81 KDM4A (0.60) KDM4ATRPV1CNR1POLBCYP2D6
SCHEMBL5725233 0.81 NPC1 (0.73) NPC1RAB9AHSP90AA1TRPV1MLYCD
SCHEMBL6443745 0.80 CTSS (0.47) NPC1RAB9ASMN1; SMN2CNR1
SCHEMBL6443540 0.78 CTSK (0.60) NPC1RAB9ASMN1; SMN2
SCHEMBL11176654 0.78 NPC1 (0.90) NPC1RAB9ASMN1; SMN2HSP90AA1MLYCD
SCHEMBL4651392 0.77 GRIA1 (0.73) TRPV1KMT2A
SCHEMBL8115111 0.77 NPC1 (0.87) NPC1RAB9ASMN1; SMN2HSP90AA1TRPV1
SCHEMBL14020485 0.74 NPC1 (0.92) NPC1RAB9ASMN1; SMN2HSP90AA1MLYCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1301474-A2 TYROSINE DERIVATIVES AS PHOSPHATASE INHIBITORS Array Biopharma Inc. (US) 2003-04-16 EP disclosed
WO-2002004412-A2 TYROSINE DERIVATIVES AS PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2002-01-17 WO disclosed